These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8475456)

  • 1. Importance of early exposure to 13-cis retinoic acid to induce teratogenicity in the cynomolgus monkey.
    Korte R; Hummler H; Hendrickx AG
    Teratology; 1993 Jan; 47(1):37-45. PubMed ID: 8475456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of malformations in the cynomolgus monkey with 13-cis retinoic acid.
    Hummler H; Korte R; Hendrickx AG
    Teratology; 1990 Sep; 42(3):263-72. PubMed ID: 2274892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Teratogenicity of all-trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis).
    Hendrickx AG; Hummler H
    Teratology; 1992 Jan; 45(1):65-74. PubMed ID: 1731397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
    Hummler H; Hendrickx AG; Nau H
    Teratology; 1994 Sep; 50(3):184-93. PubMed ID: 7871482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isotretinoin (13-cis-retinoic acid) on the development of mouse limbs in vivo and in vitro.
    Kwasigroch TE; Bullen M
    Teratology; 1991 Dec; 44(6):605-16. PubMed ID: 1805431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoid teratogenicity in the macaque: verification of dosing regimen.
    Hendrickx AG; Tzimas G; Korte R; Hummler H
    J Med Primatol; 1998 Dec; 27(6):310-8. PubMed ID: 10203012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists.
    Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
    Eckhoff C; Willhite CC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of developmental toxicology of aspirin (acetylsalicylic acid) in rats using selected dosing paradigms.
    Gupta U; Cook JC; Tassinari MS; Hurtt ME
    Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):27-37. PubMed ID: 12852481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin A teratogenicity and risk assessment in the macaque retinoid model.
    Hendrickx AG; Peterson P; Hartmann D; Hummler H
    Reprod Toxicol; 2000; 14(4):311-23. PubMed ID: 10908834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isotretinoin teratogenicity in mouse whole embryo culture.
    Goulding EH; Pratt RM
    J Craniofac Genet Dev Biol; 1986; 6(2):99-112. PubMed ID: 3459732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axial skeletal and Hox expression domain alterations induced by retinoic acid, valproic acid, and bromoxynil during murine development.
    Kawanishi CY; Hartig P; Bobseine KL; Schmid J; Cardon M; Massenburg G; Chernoff N
    J Biochem Mol Toxicol; 2003; 17(6):346-56. PubMed ID: 14708090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
    Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
    Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
    Nau H
    J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratogenicity of 13-cis retinoic acid and phenobarbital sodium in CF-1 mice.
    Yuschak MM; Gautieri RF
    Res Commun Chem Pathol Pharmacol; 1993 Dec; 82(3):259-78. PubMed ID: 8122027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid.
    Cisneros FJ; Gough BJ; Patton RE; Ferguson SA
    J Appl Toxicol; 2005; 25(6):470-8. PubMed ID: 16092084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isotretinoin-induced craniofacial malformations in humans and hamsters.
    Willhite CC; Hill RM; Irving DW
    J Craniofac Genet Dev Biol Suppl; 1986; 2():193-209. PubMed ID: 3491113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.